Journal of Prosthetic Dentistry
Volume 103, Issue 4 , Pages 196-201 , April 2010

Prosthodontic treatment of a patient with bisphosphonate-induced osteonecrosis of the jaw using a removable dental prosthesis with a heat-polymerized resilient liner: A clinical report

  • Matthias Göllner, DMD

      Affiliations

    • Assistant Professor, Department of Prosthodontics, University Clinic Erlangen, Erlangen, Germany
    • Corresponding Author InformationCorresponding author: Dr Matthias Göllner, Dental Clinic 2, Department of Prosthodontics, University Clinic Erlangen, Glueckstr. 11, 91054 Erlangen, GERMANY, Fax: 49-9131-8536781
    • ,
  • Stefan Holst, DMD, PhD

      Affiliations

    • Associate Professor, Department of Prosthodontics, University Clinic Erlangen, Erlangen, Germany
    • ,
  • Matthias Fenner, MD, DMD

      Affiliations

    • Specialist, Department of Oral and Maxillofacial Surgery, University Clinic Erlangen, Erlangen, Germany
    • ,
  • Johannes Schmitt, DMD

      Affiliations

    • Assistant Professor, Department of Prosthodontics, University Clinic Erlangen, Erlangen, Germany

References 

  1. Miller PD . Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis . Expert Opin Pharmacother . 2003;4:2253–2258
  2. Coleman RE . Clinical features of metastatic bone disease and risk of skeletal morbidity . Clin Cancer Res . 2006;12(20 Pt 2):62432s–66249s
  3. Coleman RE . Risks and benefits of bisphosphonates . Br J Cancer . 2008;98:1736–1740
  4. Rosen LS , Gordon D , Kaminski M , Howell A , Belch A , Mackey J , et al.   Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial . Cancer J . 2001;7:377–387
  5. Terpos E , Sezer O , Croucher PI , García-Sanz R , Boccadoro M , San Miguel J , et al.   The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network . Ann Oncol . 2009;20:1303–1317
  6. Hillner BE , Ingle JN , Berenson JR , Janjan NA , Albain KS , Lipton A , et al.   American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel . J Clin Oncol . 2000;18:1378–1391
  7. Noor M , Shoback D . Paget's disease of bone: diagnosis and treatment update . Curr Rheumatol Rep . 2000;2:67–73
  8. Rosen LS , Gordon D , Tchekmedyian NS , Yanagihara R , Hirsh V , Krzakowski M , et al.   Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial . Cancer . 2004;100:2613–2621
  9. Smith MR , Eastham J , Gleason DM , Shasha D , Tchekmedyian S , Zinner N . Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer . J Urol . 2003;169:2008–2012
  10. Rogers MJ . From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates . Calcif Tissue Int . 2004;75:451–461
  11. Hewitt C , Farah CS . Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review . J Oral Pathol Med . 2007;36:319–328
  12. Boivin GY , Chavassieux PM , Santora AC , Yates J , Meunier PJ . Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women . Bone . 2000;27:687–694
  13. Odvina CV , Zerwekh JE , Rao DS , Maalouf N , Gottschalk FA , Pak CY . Severely suppressed bone turnover: a potential complication of alendronate therapy . J Clin Endocrinol Metab . 2005;90:1294–1301
  14. Marx RE . Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic . J Oral Maxillofac Surg . 2003;61:1115–1117
  15. Ruggiero SL , Mehrotra B , Rosenberg TJ , Engroff SL . Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases . J Oral Maxillofac Surg . 2004;62:527–534
  16. Estafanía Fresco RE , Ponte Fernández R , Aguirre Urizar JM . Bisphosphonates and oral pathology II. Osteonecrosis of the jaws: review of the literature before 2005 . Med Oral Patol Oral Cir Bucal . 2006;11:E456–E461
  17. Leite AF , Figueiredo PT , Melo NS , Acevedo AC , Cavalcanti MG , Paula LM , et al.   Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review . Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2006;102:14–21
  18. Migliorati CA . Bisphosphanates and oral cavity avascular bone necrosis . J Clin Oncol . 2003;21:4253–4254
  19. Pazianas M , Miller P , Blumentals WA , Bernal M , Kothawala P . A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics . Clin Ther . 2007;29:1548–1558
  20. Khan AA , Sándor GK , Dore E , Morrison AD , Alsahli M , Amin F , et al.   Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw . J Rheumatol . 2008;35:1391–1397
  21. Wood J , Bonjean K , Ruetz S , Bellahcène A , Devy L , Foidart JM , et al.   Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid . J Pharmacol Exp Ther . 2002;302:1055–1061
  22. Kos M , Kuebler JF , Luczak K , Engelke W . Bisphosphonate-related osteonecrosis of the jaws: A review of 34 cases and evaluation of risk . J Craniomaxillofac Surg . 2009; [Epub ahead of print]
  23. Bamias A , Kastritis E , Bamia C , Moulopoulos LA , Melakopoulos I , Bozas G , et al.   Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors . J Clin Oncol . 2005;23:8580–8587
  24. Zarychanski R , Elphee E , Walton P , Johnston J . Osteonecrosis of the jaw associated with pamidronate therapy . Am J Hematol . 2006;81:73–75
  25. Kyrgidis A , Vahtsevanos K , Koloutsos G , Andreadis C , Boukovinas I , Teleioudis Z , et al.   Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients . J Clin Oncol . 2008;26:4634–4638
  26. Marx RE , Sawatari Y , Fortin M , Broumand V . Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment . J Oral Maxillofac Surg . 2005;63:1567–1575
  27. Freiberger JJ , Padilla-Burgos R , Chhoeu AH , Kraft KH , Boneta O , Moon RE , et al.   Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series . J Oral Maxillofac Surg . 2007;65:1321–1327
  28. Alons K , Kuijpers SC , de Jong E , van Merkesteyn JP . Treating low-and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases . Oral Surg Oral Med Oral Pathol Oral Radiol Endod . 2009;107:e1–e7
  29. Kawano F , Tada N , Nagao K , Matsumoto N . The influence of soft lining materials on pressure distribution . J Prosthet Dent . 1991;65:567–575
  30. Kivovics P , Jáhn M , Borbély J , Márton K . Frequency and location of traumatic ulcerations following placement of complete dentures . Int J Prosthodont . 2007;20:397–401
  31. Wagner WC , Kawano F , Dootz ER , Koran A . Dynamic viscoelastic properties of processed soft denture liners: Part I–Initial properties . J Prosthet Dent . 1995;73:471–477
  32. Taguchi N , Murata H , Hamada T , Hong G . Effect of viscoelastic properties of resilient denture liners on pressures under dentures . J Oral Rehabil . 2001;28:1003–1008
  33. Okita N , Orstavik D , Orstavik J , Ostby K . In vivo and in vitro studies on soft denture materials: microbial adhesion and tests for antibacterial activity . Dent Mater . 1991;7:155–160
  34. Yilmaz H , Aydin C , Bal BT , Ozçelik B . Effects of disinfectants on resilient denture-lining materials contaminated with Staphylococcus aureus, Streptococcus sobrinus, and Candida albicans . Quintessence Int . 2005;36:373–381
  35. Pinto JR , Mesquita MF , Henriques GE , de Arruda Nóbilo MA . Effect of thermocycling on bond strength and elasticity of 4 long-term soft denture liners . J Prosthet Dent . 2002;88:516–521
  36. Kulak-Ozkan Y , Sertgoz A , Gedik H . Effect of thermocycling on tensile bond strength of six silicone-based, resilient denture liners . J Prosthet Dent . 2003;89:303–310
  37. Aníl N , Hekimoglu C , Büyükbas N , Ercan MT . Microleakage study of various soft denture liners by autoradiography: effect of accelerated aging . J Prosthet Dent . 2000;84:394–399
  38. Madrid C , Sanz M . What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review . Clin Oral Implants Res . 2009;20(Suppl 4):87–95
  39. Saito M , Miura Y , Notani K , Kawasaki T . Stress distribution of abutments and base displacement with precision attachment- and telescopic crown-retained removable partial dentures . J Oral Rehabil . 2003;30:482–487

PII: S0022-3913(10)00052-1

doi: 10.1016/S0022-3913(10)00052-1

Journal of Prosthetic Dentistry
Volume 103, Issue 4 , Pages 196-201 , April 2010

Article Tools

* Image Usage & Resolution